Decoy Therapeutics secures $3.5M PIPE financing; shares surge
Source: SeekingAlpha
2026-06-29 09:09:32 ET
More on Salarius Pharmaceuticals
- Decoy Therapeutics Inc. (DCOY) Discusses Corporate Overview and Pipeline Progress in Antiviral Drug Development Transcript
- Seeking Alpha’s Quant Rating on Salarius Pharmaceuticals
- Financial information for Salarius Pharmaceuticals
Read the full article on Seeking Alpha
For further details see:
Decoy Therapeutics secures $3.5M PIPE financing; shares surge
Decoy Therapeutics Inc.
NASDAQ: DCOY
DCOY Trading
2.2% G/L:
$5.856 Last:
15,140 Volume:
$5.77 Open:
DCOY Latest News
June 29, 2026 09:24:13 am
Decoy Therapeutics Secures Milestone-Based Financing to Advance Antiviral Pipeline
June 29, 2026 09:03:12 am
4 Sizzling Biotech and Healthcare Companies Reporting Strategic Milestones
June 26, 2026 08:11:00 pm
Decoy Therapeutics, Inc. Announces Up to $21 Million Private Placement Financing
June 08, 2026 08:00:00 am
Decoy Therapeutics' CEO to Participate in hVIVO Capital Markets Day in London
$4,776,003
6,365,024
0.34%
7
N/A
Biotechnology & Life Sciences
Healthcare
US
Houston
